About
GlucoTrack, Inc. is a medical technology company located in Rutherford, New Jersey. Founded in 2001 and rebranded in 2021, GlucoTrack specializes in developing continuous blood glucose monitoring (CBGM) systems for individuals with diabetes. The company is publicly traded on NASDAQ under the ticker GCTK. GlucoTrack is focused on creating an innovative implantable continuous blood glucose monitor that measures glucose levels directly in the blood. This system aims to provide accurate, real-time readings with minimal calibration and without the need for external devices. The implantable sensor is designed to last up to three years, enhancing convenience and reducing skin irritation associated with traditional monitoring methods. Currently, the technology is in clinical development, with plans for FDA approval expected in late 2025. The company engages in research, development, and clinical evaluation of its technology, targeting individuals with diabetes and healthcare providers. GlucoTrack's mission is to improve diabetes management through less disruptive and more intuitive glucose sensing technologies.
Technologies
Keywords
Company Information
-
Employees 11
-
Founded 2004
-
Annual Revenue $24000
-
Total Funding $28500000
Location
301 New Jersey 17, Rutherford, New Jersey, United States, 07070